What are Biogen's profit margins?

Biogen (BIIB) runs a 75.5% gross margin and a 22.9% operating margin, with a 14.3% net margin.

Where do Biogen's ratios come from?

Every ratio is computed from Biogen's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Biogen BIIB Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	301.8%-0.1pp	301.9%-0.4pp	302.4%-0.3pp	302.7%-0.1pp	302.8%+0.5pp
Net margin	59.2%-0.8pp	59.9%-3.3pp	63.2%-0.8pp	64.1%+3.3pp	60.7%+3.0pp
EBITDA margin	109.1%+0.1pp	109%-2.4pp	111.4%+0.1pp	111.3%+5.8pp	105.4%+5.9pp
Free cash flow margin	87.8%-0.4pp	88.2%-7.4pp	95.6%+2.1pp	93.6%+3.1pp	90.5%+9.9pp
Returns
Return on equity	34.1%-1.2pp	35.3%-2.7pp	38%-1.2pp	39.2%+1.5pp	37.7%+1.1pp
Return on assets	20.8%-0.5pp	21.2%-1.3pp	22.5%-0.1pp	22.6%+1.1pp	21.5%+0.9pp
Return on invested capital	31.6%-0.4pp	32%-1.5pp	33.5%-0.3pp	33.8%+1.2pp	32.6%+1.2pp
Efficiency
Asset turnover	1.4×0.0×	1.4×0.0×	1.4×0.0×	1.4×0.0×	1.4×0.0×
Inventory turnover	77.2×-3.6×	80.8×-6.2×	87.1×-11.8×	98.8×-8.0×	106.8×-12.6×
Liquidity
Current ratio	11×+1.6×	9.3×+1.3×	8×+1.5×	6.6×+0.2×	6.3×-0.7×
Quick ratio	10.8×+1.6×	9.2×+1.3×	7.9×+1.4×	6.4×+0.2×	6.2×-0.6×
Cash ratio	4.1×+0.6×	3.4×+0.5×	3×+0.9×	2.1×+0.3×	1.8×+0.2×
Leverage
Debt-to-equity	1.5×+0.1×	1.4×0.0×	1.4×+0.1×	1.4×0.0×	1.4×-0.2×
Debt-to-assets	0.9×0.0×	0.9×0.0×	0.9×+0.1×	0.8×0.0×	0.8×-0.1×
Net debt / EBITDA	4.9×+0.3×	4.6×-0.2×	4.8×-0.2×	5×-0.9×	5.9×-1.9×
Per Share
Book value per share	$493.78+2.0%	$483.91+2.0%	$474.37+2.6%	$462.56+2.5%	$451.26+2.6%
Valuation
Market capitalization	$91.77B+8.1%	$84.89B+4.3%	$81.36B-8.6%	$89.06B-14.6%	$104.3B-9.8%
Enterprise value	$105.16B+8.0%	$97.38B+3.0%	$94.54B-8.0%	$102.71B-13.6%	$118.87B-11.0%
Price / earnings	63×+5.4×	57.6×+5.6×	52.1×-4.7×	56.8×-17.0×	73.8×-13.3×
Price / sales	9.2×+0.7×	8.5×+0.3×	8.2×-0.9×	9.1×-1.6×	10.8×-1.2×
Price / book	5×+0.3×	4.8×+0.1×	4.7×-0.6×	5.3×-1.1×	6.4×-0.9×
EV / EBITDA	38.8×+2.8×	36.1×+1.8×	34.3×-3.4×	37.8×-10.3×	48.1×-9.7×
EV / sales	10.6×+0.8×	9.8×+0.2×	9.6×-1.0×	10.5×-1.7×	12.3×-1.6×
Free cash flow yield	38.9%-3.2pp	42%-4.3pp	46.3%+4.1pp	42.2%+5.9pp	36.3%+7.6pp
Earnings yield	26.6%-2.1pp	28.7%-2.1pp	30.8%+2.1pp	28.7%+4.8pp	23.9%+3.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Biogen.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Biogen's profit margins?: Biogen (BIIB) runs a 75.5% gross margin and a 22.9% operating margin, with a 14.3% net margin.
Where do Biogen's ratios come from?: Every ratio is computed from Biogen's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.